...
首页> 外文期刊>Frontiers in Psychiatry >Altered SPECT 123I-iomazenil Binding in the Cingulate Cortex of Children with Anorexia Nervosa
【24h】

Altered SPECT 123I-iomazenil Binding in the Cingulate Cortex of Children with Anorexia Nervosa

机译:患厌食症患儿扣带皮层中SPECT 123 I-碘马西尼的结合改变

获取原文

摘要

Several lines of evidence suggest that anxiety plays a key role in the development and maintenance of anorexia nervosa (AN) in children. The purpose of this study was to examine cortical GABA(A)-benzodiazepine receptor binding before and after treatment in children beginning intensive AN treatment. Brain single-photon emission computed tomography (SPECT) measurements using~(123)I-iomazenil, which binds to GABA(A)-benzodiazepine receptors, was performed in 26 participants with AN who were enrolled in a multimodal treatment program. Sixteen of the 26 participants underwent a repeat SPECT scan immediately before discharge at conclusion of the intensive treatment program. Eating behavior and mood disturbances were assessed using Eating Attitudes Test with 26 items (EAT-26) and the short form of the Profile of Mood States (POMS). Clinical outcome scores were evaluated after a 1-year period. We examined association between relative iomazenil-binding activity in cortical regions of interest and psychometric profiles and determined which psychometric profiles show interaction effects with brain regions. Further, we determined if binding activity could predict clinical outcome and treatment changes. Higher EAT-26 scores were significantly associated with lower iomazenil-binding activity in the anterior and posterior cingulate cortex. Higher POMS subscale scores were significantly associated with lower iomazenil-binding activity in the left frontal, parietal cortex, and posterior cingulate cortex (PCC). “Depression–Dejection” and “Confusion” POMS subscale scores, and total POMS score showed interaction effects with brain regions in iomazenil-binding activity. Decreased binding in the anterior cingulate cortex and left parietal cortex was associated with poor clinical outcomes. Relative binding increases throughout the PCC and occipital gyrus were observed after weight gain in children with AN. These findings suggest that cortical GABAergic receptor binding is altered in children with AN. This may be a state-related change, which could be used to monitor and guide the treatment of eating disorders.
机译:几条证据表明,焦虑在儿童神经性厌食症(AN)的发展和维持中起着关键作用。这项研究的目的是检查开始强化AN治疗的儿童在治疗前后的皮质GABA(A)-苯并二氮杂receptor受体结合。使用〜(123)I-iomazenil与GABA(A)-苯并二氮杂receptor受体结合的脑单光子发射计算机断层扫描(SPECT)测量在26名参与多模式治疗方案的AN患者中进行。 26名参与者中的16名在重症治疗计划结束前不久即出院前进行了一次SPECT扫描。使用26项饮食饮食测试(EAT-26)和情绪状态简介(POMS)的简短形式评估饮食行为和情绪障碍。一年后评估临床结局评分。我们检查了感兴趣的皮质区域中的相对iomazenil结合活性与心理测量特征之间的关联,并确定了哪些心理测量特征显示与大脑区域的相互作用。此外,我们确定了结合活性是否可以预测临床结果和治疗变化。较高的EAT-26分数与前扣带回和后扣带回皮质中较低的iomazenil结合活性显着相关。较高的POMS子量表评分与左额叶,顶叶皮层和后扣带回皮层(PCC)的iomazenil结合活性较低显着相关。 “抑郁-沮丧”和“精神错乱” POMS分量表得分以及总POMS得分显示与脑区域在iomazenil结合活性中的相互作用。前扣带回皮层和左顶叶皮层的结合减少与不良的临床预后相关。患有AN的儿童体重增加后,观察到整个PCC和枕叶回的相对结合增加。这些发现表明,AN患儿的皮质GABA能受体结合发生了改变。这可能是与状态有关的变化,可用于监视和指导饮食失调的治疗。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号